News from Gilead Sciences

Follow

News from Gilead Sciences

Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 41 stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.

Follow

Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 41 stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.

Covered Most By

allAfrica

Center

com-unik.info

Unknown

RIA Novosti [🇷🇺-affiliated]

Lean Right

The New Times | Rwanda

Unknown

Benzinga

Center

allAfrica

Center

com-unik.info

Unknown

RIA Novosti [🇷🇺-affiliated]

Lean Right

Suggest a source

Suggest a source

Looking for a source we don't already have? Suggest one here.

---

Top Gilead Sciences News

Gilead Sciences · Rwanda

Rwanda: Gilead Sciences, Rwanda's Ministry of Health and Africa CDC Collaborate to Support Rwanda's Marburg Virus Disease Response With Antiviral Therapeutic Donation

Coverage: 2 sources

Addis Ababa, Ethiopia, October 8, 2024 -- Gilead Sciences, Inc., in collaboration with Africa CDC and Rwanda's Ministry of Health, has donated 5,100 vials of remdesivir to support Rwanda's response to the Marburg Virus Disease (MVD). This emergency donation aims to provide treatment to those affected by the virus following negotiations led by Africa CDC.See the Story

Cancer · United States

Novel Targeted Drug Approved for Stomach Cancers

100% Center coverage: 1 sources

The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of adults with advanced HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma, the agency announced Friday. “While there have been advances in the first-line treatment of locally advanced unresectable and metastatic gastric and GEJ cancers in the […]See the Story

Cancer · United States

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

100% Center coverage: 1 sources

(MedPage Today) -- Sacituzumab govitecan's (Trodelvy) accelerated approval in urothelial cancer will be voluntarily withdrawn, Gilead Sciences announced on Friday. The decision was made in consultation with the FDA and does not affect the antibody...See the Story

---

Latest News Stories

Covered Most By

allAfrica

Center

com-unik.info

Unknown

RIA Novosti [🇷🇺-affiliated]

Lean Right

The New Times | Rwanda

Unknown

Benzinga

Center

allAfrica

Center

com-unik.info

Unknown

RIA Novosti [🇷🇺-affiliated]

Lean Right

Suggest a source

Looking for a source we don't already have? Suggest one here.

Media Bias Breakdown

How is the media covering Gilead Sciences?

Gilead Sciences often is covered by Center Media sources.

9%

Center: 62%

Right: 29%

Breaking News Topics Related to Gilead Sciences

HIV

Foster City

Rwanda

California, United States

San Mateo County

United States

India